| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |